Every claim, every source.

This Nutrients review is the first to synthesize specifically what human trials of intermittent fasting (not animal work, not religious fasting) show about sex-hormone shifts in women and men. The authors identified seven human trials total: five testing time-restricted eating, one testing a 5:2 protocol, and one studying meal timing. Their headline findings for premenopausal women with obesity: intermittent fasting reduces testosterone and the free androgen index, and increases sex hormone-binding globulin — particularly when the eating window is restricted to earlier in the day. Estrogen, luteinizing hormone, and follicle-stimulating hormone showed no statistically meaningful change in the trials reviewed. In men, intermittent fasting reduced total and free testosterone in some studies, with implications for libido and lean-mass maintenance that the authors flag as concerning at longer protocol durations. The honest summary: female reproductive hormone effects are real but modest, mostly favorable for PCOS-spectrum profiles, and depend heavily on eating-window timing.

This is the first supervised controlled-feeding trial designed specifically to isolate intermittent fasting's metabolic effects from weight loss. Men with prediabetes were enrolled in a randomized crossover trial: 5 weeks of early time-restricted feeding (eTRF — a 6-hour eating window, with the last meal before 3 p.m.), followed by 5 weeks of a control schedule (12-hour eating window), then crossover. Critically, participants were fed enough food to maintain their weight in both conditions — the eating window changed, but total energy intake did not. Even without weight loss, eTRF improved insulin sensitivity, beta-cell responsiveness, systolic and diastolic blood pressure, oxidative stress (8-isoprostane), and evening appetite. The improvements demonstrate that intermittent fasting's cardiometabolic benefits are not solely mediated by weight loss — circadian alignment of eating and the duration of the daily fasting window have independent effects. The paper has been highly influential because it isolated the eating-window mechanism from the calorie-deficit mechanism.

This is one of the foundational human alternate-day fasting trials, and — importantly — the actual source of the famous "57 percent insulin drop" claim that circulates widely in popular fasting content. Sixteen nonobese adults (8 men, 8 women) fasted every other day for 22 days. The protocol alternated full fasting days with normal eating days. Body weight dropped 2.5 percent and fat mass dropped 4 percent over the three weeks. Resting metabolic rate did not change significantly through day 21, but respiratory quotient fell on day 22 — indicating a clear shift toward fat oxidation, with daily fat oxidation rising by 15 grams or more. Glucose and ghrelin remained essentially stable, but fasting insulin dropped 57±4 percent. Hunger on fasting days remained elevated throughout the protocol, suggesting that adaptation to alternate-day hunger patterns does not happen quickly. The paper concluded that alternate-day fasting is feasible in nonobese adults and produces substantial fat-oxidation and insulin-sensitivity shifts, but adherence is challenging.

This is one of the cleanest human studies on what fasting does to insulin sensitivity. Eight healthy young men (average age 25, BMI around 26) fasted for 20 hours every other day for 15 days. Before and after the protocol, the researchers measured insulin action with the gold-standard test in metabolic research: the euglycemic-hyperinsulinemic clamp, which directly tells you how much glucose insulin can move into tissues at a fixed concentration. After the 15-day intermittent-fasting block, insulin-mediated whole-body glucose uptake rose from 6.3 to 7.3 mg per kilogram per minute — about a 16 percent improvement, statistically significant. Adiponectin, a hormone that improves insulin signaling and tracks metabolic health, rose by more than 50 percent measured against the basal level. The men did not lose meaningful weight, so the change is not explained by fat loss. The study was the first in humans to show that intermittent fasting itself can directly improve how insulin works.

This 12-year prospective cohort study of 47,150 men from the Health Professionals Follow-up Study is the canonical evidence on dietary purines and gout risk. Of the men who had no history of gout at baseline, 730 developed gout over the follow-up period. The headline findings: men in the highest quintile of meat consumption had a 41 percent higher risk of gout than those in the lowest quintile (relative risk 1.41), and men in the highest quintile of seafood consumption had a 51 percent higher risk (RR 1.51). Dairy intake worked the opposite direction — highest-quintile dairy was protective, with a 44 percent lower risk (RR 0.56). Notably, purine-rich vegetables (peas, beans, mushrooms, spinach, cauliflower) showed no association with gout risk despite their purine content. The mechanism appears to be that different purine sources convert to uric acid at different rates, and the food matrix matters as much as total purine load.

This elegant human experiment isolated which variable — carbohydrate restriction or energy restriction — actually drives the metabolic response to short-term fasting. Five healthy volunteers participated in a randomized crossover protocol with two arms. In the control arm, subjects fasted for 84 hours (no food, no calories). In the lipid arm, subjects underwent the same 84-hour oral fast but received an intravenous lipid emulsion to meet resting energy requirements. The key insight: fat-derived calories supply energy without supplying carbohydrate. If energy deficit were the trigger for the fasting response, the lipid arm should blunt or eliminate the metabolic shifts. If carbohydrate absence were the trigger, the lipid arm should look identical to the control fast. Klein and Wolfe found the metabolic responses were essentially identical between arms — the same rise in ketones, free fatty acids, glycerol, palmitic acid, and the same suppression of insulin. The conclusion was clean: carbohydrate restriction, not energy deficit per se, is what flips the metabolic switch into fasting mode.

Five well-trained cyclists ate their usual mixed diet for one week, then switched to a ketogenic diet — under 20 grams of carbohydrate per day — for four weeks. Calories and protein were matched between both diets; only the fuel source changed. After four weeks of ketosis, the cyclists could ride to exhaustion just as long as before (about 150 minutes), and their peak aerobic capacity (VO2max) was unchanged. What did change was where the energy came from. At the same exercise intensity, the body burned roughly three times less glucose and four times less muscle glycogen. The respiratory quotient — the ratio that tells you whether you're burning carbs or fat — dropped from 0.83 (mostly carbs) to 0.72 (almost entirely fat). The study was an early demonstration that humans can stay in ketosis for weeks and still perform endurance work, drawing energy almost entirely from fat and ketones.